BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 6540539)

  • 21. [Blood rheology in peripheral occlusive disease. Effects of hemodilution and pentoxifylline].
    Angelkort B
    Wien Med Wochenschr; 1986; 136 Spec No():29-35. PubMed ID: 3548089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy.
    Ward A; Clissold SP
    Drugs; 1987 Jul; 34(1):50-97. PubMed ID: 3308412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pentoxifylline: a new drug for the treatment of intermittent claudication. Mechanism of action, pharmacokinetics, clinical efficacy and adverse effects.
    Aviado DM; Porter JM
    Pharmacotherapy; 1984; 4(6):297-307. PubMed ID: 6393073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical pharmacology of pentoxifylline with special reference to its hemorrheologic effect for the treatment of intermittent claudication.
    Dettelbach HR; Aviado DM
    J Clin Pharmacol; 1985; 25(1):8-26. PubMed ID: 3882773
    [No Abstract]   [Full Text] [Related]  

  • 25. [The biology of fibrinogen. The role of pentoxifylline].
    Soria J; Soria C
    J Mal Vasc; 1989; 14 Suppl A():25-8. PubMed ID: 2654312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New aspects of the pharmacology of pentoxifylline].
    Lenoble Giovannangeli M
    J Mal Vasc; 1989; 14 Suppl A():35-41. PubMed ID: 2654314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemorheology and peripheral vascular diseases: a new therapeutic approach.
    Müller R
    J Med; 1981; 12(4):209-35. PubMed ID: 7031157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pentoxifylline.
    Samlaska CP; Winfield EA
    J Am Acad Dermatol; 1994 Apr; 30(4):603-21. PubMed ID: 8157787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pentoxifylline and critical leg ischemia.
    Colgan MP; Moore DJ; Shanik GD
    J Cardiovasc Pharmacol; 1995; 25 Suppl 2():S58-60. PubMed ID: 8699863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pentoxifylline for vascular health: a brief review of the literature.
    McCarty MF; O'Keefe JH; DiNicolantonio JJ
    Open Heart; 2016; 3(1):e000365. PubMed ID: 26870389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of the clinical pharmacology and therapeutic efficacy of pentoxifylline in peripheral obstructive arterial disease.
    Di Perri T; Carandente O; Vittoria A; Guerrini M; Messa GL
    Angiology; 1984 Jul; 35(7):427-35. PubMed ID: 6540539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    J Med; 1988; 19(2):89-107. PubMed ID: 3049876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pentoxifylline -- a biomedical profile.
    Müller R
    J Med; 1979; 10(5):307-29. PubMed ID: 393789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemorheology in surgery--a review.
    Müller R; Musikić P
    Angiology; 1987 Aug; 38(8):581-92. PubMed ID: 3307545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pentoxifylline and cerebrovascular diseases.
    Marcel GA; George C
    Eur Neurol; 1983; 22 Suppl 1():89-97. PubMed ID: 6350013
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.